Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy
- PMID: 3515312
- DOI: 10.1007/BF01975473
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy
Abstract
Quinolones, chemically related to nalidixic acid, have a strong and rapid bactericidal action against Gram-negative bacteria, including Ps. aeruginosa, some Mycobacteria, Legionella and Staphylococci. Streptococci and anaerobic bacteria are usually less sensitive. The quinolones exert their bactericidal action through inhibition of the enzyme DNA gyrase. Quinolones are absorbed for 50-100% from the gastro-intestinal tract, their volume of distribution is generally high (2 l/kg) and high concentrations are reached in almost all organs. The elimination half-lives range from 4 to 14 h. The efficacy of quinolones in urinary tract infections has been shown in many studies. They also seem to be effective in many serious infections. In animal studies their efficacy was generally equal or superior to aminoglycosides. Until now only mild and infrequent side effects have been reported.
Similar articles
-
Quinolone antibacterials. An update of their pharmacology and therapeutic use.Drugs. 1994 Jun;47(6):872-901. doi: 10.2165/00003495-199447060-00003. Drugs. 1994. PMID: 7521829 Review.
-
Effect of new quinolones on the human gastrointestinal microflora.Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S193-6. doi: 10.1093/clinids/10.supplement_1.s193. Rev Infect Dis. 1988. PMID: 3279492 Review.
-
Quinolones in vitro.Pharm Weekbl Sci. 1986 Feb 21;8(1):26-8. doi: 10.1007/BF01975475. Pharm Weekbl Sci. 1986. PMID: 3960690
-
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1. J Antimicrob Chemother. 1986. PMID: 3468100
-
Review of the 4-quinolones.Infect Control. 1987 Mar;8(3):119-25. doi: 10.1017/s0195941700067291. Infect Control. 1987. PMID: 3553053 Review.
Cited by
-
Clinical role of protein binding of quinolones.Clin Pharmacokinet. 2002;41(10):741-50. doi: 10.2165/00003088-200241100-00004. Clin Pharmacokinet. 2002. PMID: 12162760 Review.
-
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.Drugs. 1987;34 Suppl 1:159-69. doi: 10.2165/00003495-198700341-00034. Drugs. 1987. PMID: 3481317
-
Clinical pharmacokinetics of the newer antibacterial 4-quinolones.Clin Pharmacokinet. 1988 Feb;14(2):96-121. doi: 10.2165/00003088-198814020-00003. Clin Pharmacokinet. 1988. PMID: 3282749 Review.
-
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1987 Apr;33(4):346-91. doi: 10.2165/00003495-198733040-00003. Drugs. 1987. PMID: 3297617 Review.
-
A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.Drugs. 1987;34 Suppl 1:56-61. doi: 10.2165/00003495-198700341-00013. Drugs. 1987. PMID: 3481329
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical